Press

Collaboratively, Charlie Boyer and Marty Smithmyer will work on the vision, strategy, and culture of Americord moving forward.

Americord has partnered with Veritas Genetics, a LetsGetChecked company and leader in genomic screening, to offer newborn and maternal whole-genome screening.

Americord’s proprietary CryoMaxx™ Processing method isolates and concentrates the exosomes from the plasma portion of the cord blood.

This is the story of how a younger brother's banked cord blood stem cells were used to successfully treat his older brother's Sickle Cell Disease.

Sickle cell diseases affects more than 20 million people globally, according to the National Heart, Lung, and Blood Institute.

When Amanda and Shawn Fohs’ daughter, Olivia, was born in 2013, the couple decided to bank their daughter’s cord blood stem cells.

Known for its proprietary stem cell and placental tissue processing technologies, Americord’s lab provides the environment for scientists to create a new generation of innovative products.

Casey will lead all marketing initiatives in close collaboration with research and development and sales to further position Americord as the trusted industry leader.

Americord’s release allowed doctors to treat a child with sickle cell disease with cord blood stem cells from a sibling who did not have the condition.